Description

3-Fluoro-α-Methyl-4-(4-Ethyl-5-Methyl-2-Thiazolyl)Benzeneacetic Acid is a high-purity, non-steroidal anti-inflammatory drug (NSAID) intermediate of significant commercial and research interest. This compound is valued for its precise chemical structure, which is critical for the synthesis of advanced pharmaceutical agents targeting inflammation and pain. It is primarily required by pharmaceutical R&D laboratories, fine chemical manufacturers, and contract development and manufacturing organizations (CDMOs) engaged in the development of novel therapeutic molecules.

Application

• Key Intermediate in NSAID Synthesis: Serves as a crucial building block in the production of next-generation non-steroidal anti-inflammatory drugs.
• Pharmaceutical Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the development of new anti-inflammatory candidates.
• Active Pharmaceutical Ingredient (API) Manufacturing: Employed in the scaled-up synthesis of proprietary anti-inflammatory APIs.
• Biochemical Research: Utilized as a tool compound in pharmacological studies to investigate cyclooxygenase (COX) enzyme inhibition pathways.
• Fine Chemical Production: Acts as a specialized intermediate for synthesizing complex, fluorinated organic molecules with targeted biological activity.

Basic Information

Product Name	3-Fluoro-α-Methyl-4-(4-Ethyl-5-Methyl-2-Thiazolyl)Benzeneacetic Acid
CAS No.	138568-77-1
Molecular Formula	C₁₅H₁₆FNO₂S
Molecular Weight	293.36 g/mol
Synonyms	3-Fluoro-α-methyl-4-(4-ethyl-5-methyl-2-thiazolyl)benzeneacetic acid; 2-[3-Fluoro-4-(4-ethyl-5-methyl-1,3-thiazol-2-yl)phenyl]propanoic acid; 138568-77-1; Fluorothiazolylphenylpropionic Acid; α-Methyl-3-fluoro-4-(4-ethyl-5-methyl-2-thiazolyl)benzeneacetic acid; 4-(4-Ethyl-5-methyl-2-thiazolyl)-3-fluoro-α-methylbenzeneacetic acid
EINECS	Contact for details

Quality Control

Our 3-Fluoro-α-Methyl-4-(4-Ethyl-5-Methyl-2-Thiazolyl)Benzeneacetic Acid is produced under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical intermediate applications. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from strong bases and oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.